Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rick Winningham Insider Profile
4 Followers
Rick Winningham, CEO, Director at Theravance Biopharma, holds 1.91M shares in Theravance Biopharma (Ticker: TBPH), holds 12.69K shares in Jazz Pharmaceuticals (Ticker: JAZZ), holds 0.00 shares in OncoMed Pharma (Ticker: OMED).
Rick Winningham Theravance Biopharma (TBPH)CEO, Director
Theravance Biopharma (TBPH)
CEO, Director
Ranked #12,958 out of 99,335 Corporate Insiders
Profitable Transactions
7 out of 14 Profitable Transactions
Average Return
+10.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Rick Winningham holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 17, 2015 - Aug 17, 2016
Return:+131.70%
The most profitable trade made by Rick Winningham
Rick Winningham's Trading History
Theravance Biopharma
Nov 22, 2024
CEO, Director
Uninformative Sell
159.49K
$18.06M
Jazz Pharmaceuticals
Aug 06, 2024
Director
Uninformative Buy
―
$1.61M
OncoMed Pharma
―
―
―
$0.00
Innoviva
Aug 19, 2014
Director
Uninformative Sell
―
$15.81M
List of latest transactions for each holding click on a transaction to see Rick Winningham's performance on stock
You May Also Like
Rick Winningham insider profile FAQ
What is the percentage of profitable transactions made by Rick Winningham?
The percentage of profitable transactions made by Rick Winningham is 50%.
What is the average return per transaction made by Rick Winningham?
The average return per transaction made by Rick Winningham is 10.30%.
What stocks does Rick Winningham hold?
Rick Winningham holds: TBPH, JAZZ, OMED, INVA stocks.
What was Rick Winningham’s latest transaction?
Rick Winningham latest transaction was an Uninformative Sell of $159.49K.
What was Rick Winningham's most profitable transaction?
Rick Winningham’s most profitable transaction was an Informative Buy of TBPH stock on August 17, 2015. The return on the trade was 131.70%.
What is Rick Winningham's role in Theravance Biopharma?
Rick Winningham's role in Theravance Biopharma is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.